Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-06-27
1996-11-19
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514318, 514327, 514329, 514353, 514357, 514535, 514363, 514595, 546192, 546193, 546215, 546216, 546223, 546224, 546229, 546231, 560 34, 562439, 564 44, A61K 31235, A61K 3117, C07D21192, C07D22500
Patent
active
055763340
ABSTRACT:
The invention concerns chemical compounds of formula I
REFERENCES:
patent: 5039805 (1991-08-01), Alig et al.
patent: 5084466 (1992-01-01), Alig et al.
patent: 5227490 (1993-07-01), Hartman et al.
patent: 5254573 (1993-10-01), Bovy et al.
patent: 5264420 (1993-11-01), Duggan et al.
patent: 5276049 (1994-01-01), Himmelsbach et al.
patent: 5281585 (1994-01-01), Duggan et al.
Alig, et al., "Low Molecular Weight, Non-peptide Fibrinogen Receptor Antagonists", J. Med. Chem., 1992, 35, 4393-4407.
Hartman, et al., "Non-peptide Fibrinogen Receptor Antagonists 1. Discovery and Design of Exosite Inhibitors", J. Med. Chem., 1992, 35, 4640-4642.
Brown George R.
Shute Richard E.
Compton Raymond
Ivy C. Warren
Zeneca Limited
LandOfFree
Acylurea derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acylurea derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acylurea derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-541304